No useful predictor of risk of acute heart failure in peripheral-blood stem
-cell transplantation (PBSCT) regimens, including high-dose cyclophosphamid
e, has previously been available. Corrected QT dispersion can predict acute
heart failure after high-dose cyclophosphamide chemotherapy used in PBSCT.